Loading data
NABLNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 508.84 m USD | 465.55 m USD | 422.16 m USD | 371.77 m USD | 346.46 m USD |
| Cost of revenue | 117.36 m USD | 80.87 m USD | 68.27 m USD | 58.61 m USD | 52.43 m USD |
| Gross profit | 391.48 m USD | 384.68 m USD | 353.89 m USD | 313.16 m USD | 294.02 m USD |
| Research and development expense | 100.71 m USD | 90.71 m USD | 78.18 m USD | 63.48 m USD | 53.96 m USD |
| Operating profit | 33.9 m USD | 81.88 m USD | 70.37 m USD | 47.4 m USD | 33.33 m USD |
| Profit before tax | -167 k USD | 54.08 m USD | 44.73 m USD | 30.43 m USD | 11.59 m USD |
| Income tax expense | 18.65 m USD | 23.34 m USD | 20.91 m USD | 13.72 m USD | 11.48 m USD |
| Net income (reported basis) | -18.82 m USD | 30.74 m USD | 23.82 m USD | 16.71 m USD | 113 k USD |
| Net income attributable to common shareholders | — | — | — | 16.71 m USD | 113 k USD |
| Basic earnings per share | -0.1 USD/share | 0.17 USD/share | 0.13 USD/share | 0.09 USD/share | 0 USD/share |
| Diluted earnings per share | -0.1 USD/share | 0.16 USD/share | 0.13 USD/share | 0.09 USD/share | 0 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.